To further investigate the link between ASCL1 and FOXA2, we examined the expression of FOXA2 and its correlation with ASCL1 in a cohort of patients with PRAD and NEPC (3, 9). This evidence concerns the gene FOXA2 and prostate adenocarcinoma.